Nautilus Biotechnolgy's total assets for Q4 2025 were $191.11M, a decrease of -4.88% from the previous quarter. NAUT total liabilities were $34.14M for the fiscal quarter, a 7.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.